{"id":"https://openalex.org/W5918902","doi":null,"title":"[Chiral switch: pure enantiomers of drugs instead of racemic mixtures].","display_name":"[Chiral switch: pure enantiomers of drugs instead of racemic mixtures].","publication_year":2004,"publication_date":"2004-11-01","ids":{"openalex":"https://openalex.org/W5918902","mag":"5918902","pmid":"https://pubmed.ncbi.nlm.nih.gov/15630994"},"language":"cs","primary_location":{"id":"pmid:15630994","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15630994","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036271779","display_name":"Jindra Valentov\u00e1","orcid":"https://orcid.org/0000-0002-0860-8921","observed_orcids":["https://orcid.org/0000-0002-0860-8921"]},"institutions":[{"id":"https://openalex.org/I74788687","display_name":"Comenius University Bratislava","ror":"https://ror.org/0587ef340","country_code":"SK","type":"education","lineage":["https://openalex.org/I74788687"]}],"countries":["SK"],"is_corresponding":false,"raw_author_name":"J Valentov\u00e1","raw_affiliation_strings":["Katedra chemickej te\u00f3rie lieciv Farmaceutickej fakulty Univerzity Komensk\u00e9ho, Bratislava. valentova@rec.uniba.sk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Katedra chemickej te\u00f3rie lieciv Farmaceutickej fakulty Univerzity Komensk\u00e9ho, Bratislava. valentova@rec.uniba.sk","institution_ids":["https://openalex.org/I74788687"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112183999","display_name":"A J Hutt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A J Hutt","raw_affiliation_strings":["Institute of Pharmaceutical Science"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Science","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":6.708e-05,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"53","issue":"6","first_page":"285","last_page":"93"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.7035999894142151,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.7035999894142151,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12527","display_name":"Chemistry and Stereochemistry Studies","score":0.18569999933242798,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.017500000074505806,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chiral-switch","display_name":"chiral switch","score":0.9829999804496765},{"id":"https://openalex.org/keywords/racemate","display_name":"racemic mixtures","score":0.9660000205039978},{"id":"https://openalex.org/keywords/drug-enantiomers","display_name":"drug enantiomers","score":0.8149999976158142},{"id":"https://openalex.org/keywords/enantiomeric-separation","display_name":"enantiomer separation","score":0.8149999976158142},{"id":"https://openalex.org/keywords/asymmetric-synthesis","display_name":"asymmetric synthesis","score":0.8529999852180481},{"id":"https://openalex.org/keywords/chiral-drugs","display_name":"chiral drugs","score":0.6669999957084656},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7039999961853027},{"id":"https://openalex.org/keywords/pharmacoeconomics","display_name":"pharmacoeconomics","score":0.5}],"concepts":[{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.9515005350112915},{"id":"https://openalex.org/C124668440","wikidata":"https://www.wikidata.org/wiki/Q2305173","display_name":"Chirality (physics)","level":5,"score":0.5946393013000488},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5619504451751709},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5612457990646362},{"id":"https://openalex.org/C2781219336","wikidata":"https://www.wikidata.org/wiki/Q467717","display_name":"Racemic mixture","level":3,"score":0.4870153069496155},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4433947205543518},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35324692726135254},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.26828622817993164},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1528589427471161},{"id":"https://openalex.org/C7602139","wikidata":"https://www.wikidata.org/wiki/Q6718","display_name":"Quark","level":2,"score":0.0},{"id":"https://openalex.org/C52703039","wikidata":"https://www.wikidata.org/wiki/Q5101837","display_name":"Chiral symmetry breaking","level":3,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C20621625","wikidata":"https://www.wikidata.org/wiki/Q6961432","display_name":"Nambu\u2013Jona-Lasinio model","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:15630994","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15630994","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti","raw_type":"English Abstract"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/e49da91b-4b20-4ba8-9bf7-69acac0864ef","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/e49da91b-4b20-4ba8-9bf7-69acac0864ef","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Valentova, J & Hutt, A J 2004, '[Chiral switch: pure enantiomers of drugs instead of racemic mixtures]. [Czech]', Ceska A Slovenska Farmacie, vol. 53, no. 6, pp. 285 - 293.","raw_type":"info:eu-repo/semantics/publishedVersion"},{"id":"mag:5918902","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15630994","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1978447274","https://openalex.org/W2015150977","https://openalex.org/W2066329114","https://openalex.org/W2128387089","https://openalex.org/W2001428258","https://openalex.org/W2492752427"],"related_works":["https://openalex.org/W7065006200","https://openalex.org/W2372095914","https://openalex.org/W2187006251","https://openalex.org/W1463581258","https://openalex.org/W4212777366","https://openalex.org/W4234436622","https://openalex.org/W1991998089","https://openalex.org/W2996143909","https://openalex.org/W3147173980","https://openalex.org/W2033261190"],"abstract_inverted_index":{"Chirality":[0],"of":[1,6,8,18,21,41,59,67,84,93,100,121],"drugs,":[2],"particularly":[3],"the":[4,36,57,68,90,94,108,122,125],"comparison":[5],"efficacy":[7],"enantiomers":[9,43,86],"and":[10,39,116,133,144],"their":[11],"racemic":[12,102],"mixtures,":[13],"has":[14],"become":[15],"an":[16,54],"object":[17],"serious":[19],"interest":[20],"pharmaceutical":[22],"researchers":[23],"in":[24,31,53,56],"recent":[25],"ten":[26],"or":[27],"fifteen":[28],"years.":[29],"Advances":[30],"chemical":[32,72],"technologies":[33],"connected":[34],"with":[35,47,104],"synthesis,":[37],"separation,":[38],"analysis":[40],"pure":[42,85,106],"from":[44],"racemates,":[45],"together":[46],"administrative":[48],"regulatory":[49],"measures,":[50],"have":[51,137],"resulted":[52],"increase":[55],"number":[58],"newly":[60],"registered":[61],"chiral":[62,148],"drugs":[63,112,117],"containing":[64,113,118],"only":[65,119],"one":[66,120],"enantiomers.":[69,123],"Besides":[70],"new":[71,82],"entities,":[73],"many":[74],"\"old\"":[75],"racemates":[76],"are":[77],"being":[78],"re-evaluated":[79],"as":[80],"potentially":[81],"sources":[83],"which":[87],"should":[88],"improve":[89],"therapeutic":[91,127,143],"profile":[92],"drug.":[95],"Due":[96],"to":[97],"this":[98],"replacement":[99],"a":[101,105,114],"mixture":[103],"enantiomer,":[107],"literature":[109],"lists":[110],"both":[111],"racemate":[115],"Nevertheless,":[124],"required":[126],"effect":[128],"is":[129],"not":[130],"always":[131],"achieved,":[132],"unexpected":[134],"undesirable":[135],"effects":[136],"also":[138],"occurred.":[139],"The":[140],"paper":[141],"summarizes":[142],"economic":[145],"problems":[146],"concerning":[147],"switch":[149],"drugs.":[150]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}